Q3 2020 Sales Performance

Adjusted operating profit to net income Continued delivery of financial efficiency Q3 19 Q3 20 £m £m Operating profit 2,786 2,665 Net finance expense (206) (197) Share of associates 17 11 Tax (411) (417) Tax rate 15.8% 16.8% Minorities (275) (287) Net income 1,911 1,775 93 33 gsk

View entire presentation